KEGG   PATHWAY: dle05211
Entry
dle05211                    Pathway                                
Name
Renal cell carcinoma - Delphinapterus leucas (beluga whale)
Description
Renal cell cancer (RCC) accounts for ~3% of human malignancies and its incidence appears to be rising. Although most cases of RCC seem to occur sporadically, an inherited predisposition to renal cancer accounts for 1-4% of cases. RCC is not a single disease, it has several morphological subtypes. Conventional RCC (clear cell RCC) accounts for ~80% of cases, followed by papillary RCC (10-15%), chromophobe RCC (5%), and collecting duct RCC (<1%). Genes potentially involved in sporadic neoplasms of each particular type are VHL, MET, BHD, and FH respectively. In the absence of VHL, hypoxia-inducible factor alpha (HIF-alpha) accumulates, leading to production of several growth factors, including vascular endothelial growth factor and platelet-derived growth factor. Activated MET mediates a number of biological effects including motility, invasion of extracellular matrix, cellular transformation, prevention of apoptosis and metastasis formation. Loss of functional FH leads to accumulation of fumarate in the cell, triggering inhibition of HPH and preventing targeted pVHL-mediated degradation of HIF-alpha. BHD mutations cause the Birt-Hogg-Dube syndrome and its associated chromophobe, hybrid oncocytic, and conventional (clear cell) RCC.
Class
Human Diseases; Cancer: specific types
Pathway map
dle05211  Renal cell carcinoma
dle05211

Organism
Delphinapterus leucas (beluga whale) [GN:dle]
Gene
111173087  HIF1A; hypoxia-inducible factor 1-alpha isoform X1 [KO:K08268]
111174799  EPAS1; endothelial PAS domain-containing protein 1 isoform X1 [KO:K09095]
111173240  EGLN3; egl nine homolog 3 [KO:K09592] [EC:1.14.11.29]
111180833  EGLN2; egl nine homolog 2 [KO:K09592] [EC:1.14.11.29]
111163986  EGLN1; egl nine homolog 1 isoform X1 [KO:K09592] [EC:1.14.11.29]
111169977  LOW QUALITY PROTEIN: von Hippel-Lindau disease tumor suppressor-like [KO:K03871]
111169978  von Hippel-Lindau disease tumor suppressor [KO:K03871]
111185598  ELOC; elongin-C [KO:K03872]
111185208  ELOB; elongin-B [KO:K03873]
111186303  RBX1; E3 ubiquitin-protein ligase RBX1 [KO:K03868] [EC:2.3.2.32]
111178032  CUL2; cullin-2 [KO:K03870]
111169763  ARNT; aryl hydrocarbon receptor nuclear translocator isoform X1 [KO:K09097]
111164743  ARNT2; aryl hydrocarbon receptor nuclear translocator 2 isoform X1 [KO:K15589]
111185248  CREBBP; CREB-binding protein isoform X1 [KO:K04498] [EC:2.3.1.48]
111186470  EP300; histone acetyltransferase p300 [KO:K04498] [EC:2.3.1.48]
111175689  SLC2A1; solute carrier family 2, facilitated glucose transporter member 1 isoform X1 [KO:K07299]
111178866  VEGFA; vascular endothelial growth factor A isoform X1 [KO:K05448]
111180824  TGFB1; transforming growth factor beta-1 proprotein isoform X1 [KO:K13375]
111177477  TGFB2; transforming growth factor beta-2 proprotein isoform X1 [KO:K13376]
111176232  TGFB3; transforming growth factor beta-3 proprotein [KO:K13377]
111186344  PDGFB; platelet-derived growth factor subunit B isoform X1 [KO:K17386]
111167945  TGFA; protransforming growth factor alpha isoform X1 [KO:K08774]
111164604  HGF; hepatocyte growth factor isoform X1 [KO:K05460]
111179292  MET; hepatocyte growth factor receptor isoform X1 [KO:K05099] [EC:2.7.10.1]
111187768  GAB1; GRB2-associated-binding protein 1 isoform X1 [KO:K09593]
111173839  PIK3CA; phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform [KO:K00922] [EC:2.7.1.153]
111179235  PIK3CB; phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform isoform X1 [KO:K00922] [EC:2.7.1.153]
111187262  PIK3CD; phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform [KO:K00922] [EC:2.7.1.153]
111166652  PIK3R2; phosphatidylinositol 3-kinase regulatory subunit beta [KO:K02649]
111185984  PIK3R1; phosphatidylinositol 3-kinase regulatory subunit alpha isoform X1 [KO:K02649]
111175760  phosphatidylinositol 3-kinase regulatory subunit gamma isoform X1 [KO:K02649]
111177559  AKT3; RAC-gamma serine/threonine-protein kinase [KO:K04456] [EC:2.7.11.1]
111176008  AKT1; RAC-alpha serine/threonine-protein kinase isoform X1 [KO:K04456] [EC:2.7.11.1]
111180855  AKT2; RAC-beta serine/threonine-protein kinase [KO:K04456] [EC:2.7.11.1]
111183810  BAD; bcl2-associated agonist of cell death [KO:K02158]
111185687  CRK; adapter molecule crk isoform X1 [KO:K04438]
111162913  CRKL; crk-like protein [KO:K04438]
111177101  RAPGEF1; rap guanine nucleotide exchange factor 1 isoform X1 [KO:K06277]
111180034  RAP1A; ras-related protein Rap-1A [KO:K04353]
111173766  RAP1B; ras-related protein Rap-1b [KO:K07836]
111188123  PTPN11; tyrosine-protein phosphatase non-receptor type 11 isoform X1 [KO:K07293] [EC:3.1.3.48]
111187198  tyrosine-protein phosphatase non-receptor type 11-like [KO:K07293] [EC:3.1.3.48]
111182833  GRB2; growth factor receptor-bound protein 2 [KO:K04364]
111174855  SOS1; son of sevenless homolog 1 isoform X1 [KO:K03099]
111173177  SOS2; son of sevenless homolog 2 isoform X1 [KO:K03099]
111170340  HRAS; GTPase HRas isoform X1 [KO:K02833]
111176851  KRAS; GTPase KRas [KO:K07827]
111179996  NRAS; GTPase NRas [KO:K07828]
111165554  ARAF; serine/threonine-protein kinase A-Raf isoform X1 [KO:K08845] [EC:2.7.11.1]
111177653  BRAF; serine/threonine-protein kinase B-raf isoform X1 [KO:K04365] [EC:2.7.11.1]
111168973  RAF1; RAF proto-oncogene serine/threonine-protein kinase isoform X1 [KO:K04366] [EC:2.7.11.1]
111177745  MAP2K1; dual specificity mitogen-activated protein kinase kinase 1 [KO:K04368] [EC:2.7.12.2]
111165994  MAP2K2; dual specificity mitogen-activated protein kinase kinase 2 isoform X1 [KO:K04369] [EC:2.7.12.2]
111163022  MAPK1; mitogen-activated protein kinase 1 isoform X1 [KO:K04371] [EC:2.7.11.24]
111182181  MAPK3; mitogen-activated protein kinase 3 [KO:K04371] [EC:2.7.11.24]
111165523  ETS1; protein C-ets-1 isoform X1 [KO:K02678]
111175871  JUN; transcription factor AP-1 [KO:K04448]
111181886  RAC1; ras-related C3 botulinum toxin substrate 1 [KO:K04392]
111163214  CDC42; cell division control protein 42 homolog isoform X1 [KO:K04393]
111175094  LOW QUALITY PROTEIN: cell division control protein 42 homolog [KO:K04393]
111184900  PAK1; serine/threonine-protein kinase PAK 1 [KO:K04409] [EC:2.7.11.1]
111172258  PAK2; serine/threonine-protein kinase PAK 2 isoform X1 [KO:K04410] [EC:2.7.11.1]
111165746  PAK3; serine/threonine-protein kinase PAK 3 isoform X1 [KO:K05733] [EC:2.7.11.1]
111180877  PAK4; serine/threonine-protein kinase PAK 4 [KO:K05734] [EC:2.7.11.1]
111165611  PAK5; serine/threonine-protein kinase PAK 5 [KO:K05736] [EC:2.7.11.1]
111181755  LOW QUALITY PROTEIN: serine/threonine-protein kinase PAK 6-like [KO:K05735] [EC:2.7.11.1]
111167185  PRCC; proline-rich protein PRCC isoform X1 [KO:K13105]
111169489  TFE3; transcription factor E3 isoform X1 [KO:K09105]
111178743  CDKN1A; cyclin-dependent kinase inhibitor 1 [KO:K06625]
111177564  FH; fumarate hydratase, mitochondrial [KO:K01679] [EC:4.2.1.2]
111167696  FLCN; folliculin isoform X1 [KO:K09594]
Compound
C00007  Oxygen
C00122  Fumarate
C00149  (S)-Malate
Reference
  Authors
Cohen HT, McGovern FJ.
  Title
Renal-cell carcinoma.
  Journal
N Engl J Med 353:2477-90 (2005)
DOI:10.1056/NEJMra043172
Reference
  Authors
Pavlovich CP, Schmidt LS.
  Title
Searching for the hereditary causes of renal-cell carcinoma.
  Journal
Nat Rev Cancer 4:381-93 (2004)
DOI:10.1038/nrc1364
Reference
  Authors
Linehan WM, Walther MM, Zbar B.
  Title
The genetic basis of cancer of the kidney.
  Journal
J Urol 170:2163-72 (2003)
DOI:10.1097/01.ju.0000096060.92397.ed
Reference
  Authors
Kim WY, Kaelin WG.
  Title
Role of VHL gene mutation in human cancer.
  Journal
J Clin Oncol 22:4991-5004 (2004)
DOI:10.1200/JCO.2004.05.061
Reference
  Authors
Sudarshan S, Linehan WM, Neckers L.
  Title
HIF and fumarate hydratase in renal cancer.
  Journal
Br J Cancer 96:403-7 (2007)
DOI:10.1038/sj.bjc.6603547
Reference
  Authors
Sudarshan S, Pinto PA, Neckers L, Linehan WM.
  Title
Mechanisms of disease: hereditary leiomyomatosis and renal cell cancer--a distinct form of hereditary kidney cancer.
  Journal
Nat Clin Pract Urol 4:104-10 (2007)
DOI:10.1038/ncpuro0711
Reference
  Authors
Birchmeier C, Birchmeier W, Gherardi E, Vande Woude GF.
  Title
Met, metastasis, motility and more.
  Journal
Nat Rev Mol Cell Biol 4:915-25 (2003)
DOI:10.1038/nrm1261
Reference
  Authors
Muller-Hocker J, Babaryka G, Schmid I, Jung A
  Title
Overexpression of cyclin D1, D3, and p21 in an infantile renal carcinoma with Xp11.2 TFE3-gene fusion.
  Journal
Pathol Res Pract 204:589-97 (2008)
DOI:10.1016/j.prp.2008.01.010
Reference
  Authors
Bodmer D, van den Hurk W, van Groningen JJ, Eleveld MJ, Martens GJ, Weterman MA, van Kessel AG.
  Title
Understanding familial and non-familial renal cell cancer.
  Journal
Hum Mol Genet 11:2489-98 (2002)
DOI:10.1093/hmg/11.20.2489
Reference
  Authors
Kauffman EC, Ricketts CJ, Rais-Bahrami S, Yang Y, Merino MJ, Bottaro DP, Srinivasan R, Linehan WM
  Title
Molecular genetics and cellular features of TFE3 and TFEB fusion kidney cancers.
  Journal
Nat Rev Urol 11:465-75 (2014)
DOI:10.1038/nrurol.2014.162
Reference
  Authors
Skalsky YM, Ajuh PM, Parker C, Lamond AI, Goodwin G, Cooper CS
  Title
PRCC, the commonest TFE3 fusion partner in papillary renal carcinoma is associated with pre-mRNA splicing factors.
  Journal
Oncogene 20:178-87 (2001)
DOI:10.1038/sj.onc.1204056
Reference
  Authors
Medendorp K, van Groningen JJ, Vreede L, Hetterschijt L, Brugmans L, van den Hurk WH, van Kessel AG
  Title
The renal cell carcinoma-associated oncogenic fusion protein PRCCTFE3 provokes p21 WAF1/CIP1-mediated cell cycle delay.
  Journal
Exp Cell Res 315:2399-409 (2009)
DOI:10.1016/j.yexcr.2009.04.022
Related
pathway
dle00020  Citrate cycle (TCA cycle)
dle04010  MAPK signaling pathway
dle04066  HIF-1 signaling pathway
dle04120  Ubiquitin mediated proteolysis
dle04350  TGF-beta signaling pathway
dle04370  VEGF signaling pathway
KO pathway
ko05211   
LinkDB

DBGET integrated database retrieval system